Shanghai Henlius Biotech, Inc. (HKG:2696)
69.55
-2.40 (-3.34%)
Feb 13, 2026, 3:05 PM HKT
Shanghai Henlius Biotech Employees
Shanghai Henlius Biotech had 3,537 employees as of June 30, 2025. The number of employees increased by 22 or 0.63% since the number was reported on December 31, 2024.
Employees
3,537
Change
22
Growth
0.63%
Revenue / Employee
1.80M HKD
Profits / Employee
255.37K HKD
Market Cap
39.10B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 3,537 | 22 | 0.63% |
| Dec 31, 2024 | 3,515 | -122 | -3.35% |
| Dec 31, 2023 | 3,637 | 231 | 6.78% |
| Dec 31, 2022 | 3,406 | 1,172 | 52.46% |
| Dec 31, 2021 | 2,234 | 361 | 19.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| 3SBio | 6,268 |
| Genscript Biotech | 5,769 |
| RemeGen | 3,070 |
| Shanghai Junshi Biosciences | 2,670 |
| Biocytogen Pharmaceuticals (Beijing) | 1,306 |
| InnoCare Pharma | 1,176 |
| Ascentage Pharma Group International | 605 |
| Ascletis Pharma | 208 |